nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticlopidine—CYP2C8—Mometasone—systemic scleroderma	0.163	0.267	CbGbCtD
Ticlopidine—CYP1A2—Pentoxifylline—systemic scleroderma	0.085	0.139	CbGbCtD
Ticlopidine—CYP1A2—Leflunomide—systemic scleroderma	0.0811	0.133	CbGbCtD
Ticlopidine—CYP2C9—Leflunomide—systemic scleroderma	0.073	0.12	CbGbCtD
Ticlopidine—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0647	0.106	CbGbCtD
Ticlopidine—CYP2D6—Captopril—systemic scleroderma	0.0524	0.086	CbGbCtD
Ticlopidine—CYP2C19—Prednisone—systemic scleroderma	0.0434	0.0712	CbGbCtD
Ticlopidine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0262	0.0431	CbGbCtD
Ticlopidine—CYP3A4—Prednisone—systemic scleroderma	0.021	0.0344	CbGbCtD
Ticlopidine—CYP2C9—cardial valve—systemic scleroderma	0.0199	0.292	CbGeAlD
Ticlopidine—P2RY12—artery—systemic scleroderma	0.0131	0.192	CbGeAlD
Ticlopidine—MPO—artery—systemic scleroderma	0.00574	0.0843	CbGeAlD
Ticlopidine—MPO—endothelium—systemic scleroderma	0.00485	0.0712	CbGeAlD
Ticlopidine—MPO—blood vessel—systemic scleroderma	0.00447	0.0657	CbGeAlD
Ticlopidine—MPO—connective tissue—systemic scleroderma	0.00229	0.0337	CbGeAlD
Ticlopidine—MPO—skin of body—systemic scleroderma	0.00207	0.0304	CbGeAlD
Ticlopidine—MPO—digestive system—systemic scleroderma	0.00166	0.0243	CbGeAlD
Ticlopidine—MPO—lung—systemic scleroderma	0.00138	0.0203	CbGeAlD
Ticlopidine—CYP1A1—skin of body—systemic scleroderma	0.00112	0.0164	CbGeAlD
Ticlopidine—CYP2C19—digestive system—systemic scleroderma	0.00111	0.0163	CbGeAlD
Ticlopidine—CYP2B6—skin of body—systemic scleroderma	0.00109	0.016	CbGeAlD
Ticlopidine—CYP1A2—digestive system—systemic scleroderma	0.000906	0.0133	CbGeAlD
Ticlopidine—CYP1A1—digestive system—systemic scleroderma	0.000894	0.0131	CbGeAlD
Ticlopidine—CYP2B6—digestive system—systemic scleroderma	0.000869	0.0128	CbGeAlD
Ticlopidine—CYP2C9—digestive system—systemic scleroderma	0.00086	0.0126	CbGeAlD
Ticlopidine—CYP2E1—digestive system—systemic scleroderma	0.000815	0.012	CbGeAlD
Ticlopidine—CYP2E1—tendon—systemic scleroderma	0.000776	0.0114	CbGeAlD
Ticlopidine—Stevens-Johnson syndrome—Lisinopril—systemic scleroderma	0.000767	0.00238	CcSEcCtD
Ticlopidine—Abdominal distension—Mycophenolate mofetil—systemic scleroderma	0.000765	0.00237	CcSEcCtD
Ticlopidine—Erythema multiforme—Leflunomide—systemic scleroderma	0.000764	0.00237	CcSEcCtD
Ticlopidine—Renal failure—Lisinopril—systemic scleroderma	0.00076	0.00236	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Lisinopril—systemic scleroderma	0.000758	0.00235	CcSEcCtD
Ticlopidine—CYP1A2—lung—systemic scleroderma	0.000757	0.0111	CbGeAlD
Ticlopidine—Anorexia—Mometasone—systemic scleroderma	0.000756	0.00234	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.000752	0.00233	CcSEcCtD
Ticlopidine—CYP1A1—lung—systemic scleroderma	0.000746	0.011	CbGeAlD
Ticlopidine—Ecchymosis—Prednisone—systemic scleroderma	0.000743	0.0023	CcSEcCtD
Ticlopidine—Haematuria—Lisinopril—systemic scleroderma	0.000738	0.00229	CcSEcCtD
Ticlopidine—Urticaria—Pentoxifylline—systemic scleroderma	0.00073	0.00226	CcSEcCtD
Ticlopidine—Epistaxis—Lisinopril—systemic scleroderma	0.00073	0.00226	CcSEcCtD
Ticlopidine—Arthralgia—Captopril—systemic scleroderma	0.000727	0.00225	CcSEcCtD
Ticlopidine—Myalgia—Captopril—systemic scleroderma	0.000727	0.00225	CcSEcCtD
Ticlopidine—Body temperature increased—Pentoxifylline—systemic scleroderma	0.000727	0.00225	CcSEcCtD
Ticlopidine—CYP2B6—lung—systemic scleroderma	0.000725	0.0107	CbGeAlD
Ticlopidine—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.000723	0.00224	CcSEcCtD
Ticlopidine—Pancytopenia—Mycophenolate mofetil—systemic scleroderma	0.000722	0.00224	CcSEcCtD
Ticlopidine—Tinnitus—Mycophenolic acid—systemic scleroderma	0.000719	0.00223	CcSEcCtD
Ticlopidine—Sepsis—Prednisone—systemic scleroderma	0.000713	0.00221	CcSEcCtD
Ticlopidine—Vasculitis—Methotrexate—systemic scleroderma	0.000703	0.00218	CcSEcCtD
Ticlopidine—Dyspepsia—Mometasone—systemic scleroderma	0.000698	0.00216	CcSEcCtD
Ticlopidine—Anaphylactic shock—Captopril—systemic scleroderma	0.000697	0.00216	CcSEcCtD
Ticlopidine—Hepatitis—Lisinopril—systemic scleroderma	0.000695	0.00215	CcSEcCtD
Ticlopidine—Flatulence—Leflunomide—systemic scleroderma	0.000693	0.00215	CcSEcCtD
Ticlopidine—Decreased appetite—Mometasone—systemic scleroderma	0.00069	0.00214	CcSEcCtD
Ticlopidine—Diabetes mellitus—Prednisone—systemic scleroderma	0.000685	0.00212	CcSEcCtD
Ticlopidine—Thrombocytopenia—Captopril—systemic scleroderma	0.000682	0.00211	CcSEcCtD
Ticlopidine—CYP2E1—lung—systemic scleroderma	0.000681	0.01	CbGeAlD
Ticlopidine—Pain—Mometasone—systemic scleroderma	0.000678	0.0021	CcSEcCtD
Ticlopidine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000677	0.0021	CcSEcCtD
Ticlopidine—Muscle spasms—Leflunomide—systemic scleroderma	0.000676	0.0021	CcSEcCtD
Ticlopidine—Vascular purpura—Prednisone—systemic scleroderma	0.000667	0.00207	CcSEcCtD
Ticlopidine—Renal failure—Mycophenolate mofetil—systemic scleroderma	0.000666	0.00206	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Mycophenolate mofetil—systemic scleroderma	0.000664	0.00206	CcSEcCtD
Ticlopidine—Anorexia—Captopril—systemic scleroderma	0.000664	0.00206	CcSEcCtD
Ticlopidine—Flatulence—Mycophenolic acid—systemic scleroderma	0.000661	0.00205	CcSEcCtD
Ticlopidine—Asthenia—Pentoxifylline—systemic scleroderma	0.00066	0.00204	CcSEcCtD
Ticlopidine—Erythema multiforme—Lisinopril—systemic scleroderma	0.000657	0.00203	CcSEcCtD
Ticlopidine—CYP3A4—digestive system—systemic scleroderma	0.000656	0.00964	CbGeAlD
Ticlopidine—Pruritus—Pentoxifylline—systemic scleroderma	0.00065	0.00202	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Mometasone—systemic scleroderma	0.000649	0.00201	CcSEcCtD
Ticlopidine—Tinnitus—Lisinopril—systemic scleroderma	0.000648	0.00201	CcSEcCtD
Ticlopidine—Haematuria—Mycophenolate mofetil—systemic scleroderma	0.000646	0.002	CcSEcCtD
Ticlopidine—CYP2D6—digestive system—systemic scleroderma	0.000645	0.00949	CbGeAlD
Ticlopidine—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.000645	0.002	CcSEcCtD
Ticlopidine—Angioedema—Leflunomide—systemic scleroderma	0.000643	0.00199	CcSEcCtD
Ticlopidine—Epistaxis—Mycophenolate mofetil—systemic scleroderma	0.000639	0.00198	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.000635	0.00197	CcSEcCtD
Ticlopidine—Arthralgia—Azathioprine—systemic scleroderma	0.000634	0.00197	CcSEcCtD
Ticlopidine—Myalgia—Azathioprine—systemic scleroderma	0.000634	0.00197	CcSEcCtD
Ticlopidine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000629	0.00195	CcSEcCtD
Ticlopidine—Body temperature increased—Mometasone—systemic scleroderma	0.000627	0.00194	CcSEcCtD
Ticlopidine—Ecchymosis—Methotrexate—systemic scleroderma	0.000621	0.00192	CcSEcCtD
Ticlopidine—Purpura—Prednisone—systemic scleroderma	0.000619	0.00192	CcSEcCtD
Ticlopidine—Dyspepsia—Captopril—systemic scleroderma	0.000613	0.0019	CcSEcCtD
Ticlopidine—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.000612	0.0019	CcSEcCtD
Ticlopidine—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.000609	0.00189	CcSEcCtD
Ticlopidine—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.000609	0.00189	CcSEcCtD
Ticlopidine—Dizziness—Pentoxifylline—systemic scleroderma	0.000608	0.00188	CcSEcCtD
Ticlopidine—Decreased appetite—Captopril—systemic scleroderma	0.000606	0.00188	CcSEcCtD
Ticlopidine—Myalgia—Leflunomide—systemic scleroderma	0.000599	0.00186	CcSEcCtD
Ticlopidine—Arthralgia—Leflunomide—systemic scleroderma	0.000599	0.00186	CcSEcCtD
Ticlopidine—Osteoarthritis—Prednisone—systemic scleroderma	0.000596	0.00185	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Prednisone—systemic scleroderma	0.000596	0.00185	CcSEcCtD
Ticlopidine—Flatulence—Lisinopril—systemic scleroderma	0.000596	0.00185	CcSEcCtD
Ticlopidine—Sepsis—Methotrexate—systemic scleroderma	0.000596	0.00185	CcSEcCtD
Ticlopidine—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000595	0.00184	CcSEcCtD
Ticlopidine—Vomiting—Pentoxifylline—systemic scleroderma	0.000585	0.00181	CcSEcCtD
Ticlopidine—Muscle spasms—Lisinopril—systemic scleroderma	0.000581	0.0018	CcSEcCtD
Ticlopidine—Rash—Pentoxifylline—systemic scleroderma	0.00058	0.0018	CcSEcCtD
Ticlopidine—Dermatitis—Pentoxifylline—systemic scleroderma	0.000579	0.00179	CcSEcCtD
Ticlopidine—Headache—Pentoxifylline—systemic scleroderma	0.000576	0.00178	CcSEcCtD
Ticlopidine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000574	0.00178	CcSEcCtD
Ticlopidine—Diabetes mellitus—Methotrexate—systemic scleroderma	0.000573	0.00178	CcSEcCtD
Ticlopidine—Arthralgia—Mycophenolic acid—systemic scleroderma	0.000571	0.00177	CcSEcCtD
Ticlopidine—Myalgia—Mycophenolic acid—systemic scleroderma	0.000571	0.00177	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Captopril—systemic scleroderma	0.00057	0.00177	CcSEcCtD
Ticlopidine—Asthenia—Mometasone—systemic scleroderma	0.000569	0.00176	CcSEcCtD
Ticlopidine—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.000567	0.00176	CcSEcCtD
Ticlopidine—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000562	0.00174	CcSEcCtD
Ticlopidine—Pruritus—Mometasone—systemic scleroderma	0.000561	0.00174	CcSEcCtD
Ticlopidine—Hepatic failure—Methotrexate—systemic scleroderma	0.000554	0.00172	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000554	0.00172	CcSEcCtD
Ticlopidine—Angioedema—Lisinopril—systemic scleroderma	0.000552	0.00171	CcSEcCtD
Ticlopidine—Body temperature increased—Captopril—systemic scleroderma	0.000551	0.00171	CcSEcCtD
Ticlopidine—Anorexia—Leflunomide—systemic scleroderma	0.000547	0.0017	CcSEcCtD
Ticlopidine—Nausea—Pentoxifylline—systemic scleroderma	0.000546	0.00169	CcSEcCtD
Ticlopidine—Diarrhoea—Mometasone—systemic scleroderma	0.000543	0.00168	CcSEcCtD
Ticlopidine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000536	0.00166	CcSEcCtD
Ticlopidine—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.000528	0.00164	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000523	0.00162	CcSEcCtD
Ticlopidine—Anorexia—Mycophenolic acid—systemic scleroderma	0.000522	0.00162	CcSEcCtD
Ticlopidine—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000522	0.00162	CcSEcCtD
Ticlopidine—Abdominal distension—Prednisone—systemic scleroderma	0.000519	0.00161	CcSEcCtD
Ticlopidine—Arthralgia—Lisinopril—systemic scleroderma	0.000515	0.00159	CcSEcCtD
Ticlopidine—Myalgia—Lisinopril—systemic scleroderma	0.000515	0.00159	CcSEcCtD
Ticlopidine—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000509	0.00158	CcSEcCtD
Ticlopidine—Dyspepsia—Leflunomide—systemic scleroderma	0.000505	0.00157	CcSEcCtD
Ticlopidine—Vomiting—Mometasone—systemic scleroderma	0.000504	0.00156	CcSEcCtD
Ticlopidine—Rash—Mometasone—systemic scleroderma	0.0005	0.00155	CcSEcCtD
Ticlopidine—Asthenia—Captopril—systemic scleroderma	0.0005	0.00155	CcSEcCtD
Ticlopidine—Dermatitis—Mometasone—systemic scleroderma	0.0005	0.00155	CcSEcCtD
Ticlopidine—Decreased appetite—Leflunomide—systemic scleroderma	0.000499	0.00155	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000499	0.00155	CcSEcCtD
Ticlopidine—Osteoarthritis—Methotrexate—systemic scleroderma	0.000498	0.00154	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000497	0.00154	CcSEcCtD
Ticlopidine—Headache—Mometasone—systemic scleroderma	0.000497	0.00154	CcSEcCtD
Ticlopidine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000493	0.00153	CcSEcCtD
Ticlopidine—Pruritus—Captopril—systemic scleroderma	0.000493	0.00153	CcSEcCtD
Ticlopidine—Pain—Leflunomide—systemic scleroderma	0.000491	0.00152	CcSEcCtD
Ticlopidine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000484	0.0015	CcSEcCtD
Ticlopidine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000483	0.0015	CcSEcCtD
Ticlopidine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000482	0.00149	CcSEcCtD
Ticlopidine—Body temperature increased—Azathioprine—systemic scleroderma	0.000481	0.00149	CcSEcCtD
Ticlopidine—Diarrhoea—Captopril—systemic scleroderma	0.000477	0.00148	CcSEcCtD
Ticlopidine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000476	0.00148	CcSEcCtD
Ticlopidine—Nausea—Mometasone—systemic scleroderma	0.000471	0.00146	CcSEcCtD
Ticlopidine—Anorexia—Lisinopril—systemic scleroderma	0.00047	0.00146	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00047	0.00145	CcSEcCtD
Ticlopidine—Pain—Mycophenolic acid—systemic scleroderma	0.000468	0.00145	CcSEcCtD
Ticlopidine—Dizziness—Captopril—systemic scleroderma	0.000461	0.00143	CcSEcCtD
Ticlopidine—Liver function test abnormal—Methotrexate—systemic scleroderma	0.00046	0.00143	CcSEcCtD
Ticlopidine—Urticaria—Leflunomide—systemic scleroderma	0.000456	0.00141	CcSEcCtD
Ticlopidine—Body temperature increased—Leflunomide—systemic scleroderma	0.000454	0.00141	CcSEcCtD
Ticlopidine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000451	0.0014	CcSEcCtD
Ticlopidine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000451	0.0014	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Prednisone—systemic scleroderma	0.00045	0.0014	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00045	0.00139	CcSEcCtD
Ticlopidine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000448	0.00139	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000448	0.00139	CcSEcCtD
Ticlopidine—Vomiting—Captopril—systemic scleroderma	0.000443	0.00137	CcSEcCtD
Ticlopidine—Rash—Captopril—systemic scleroderma	0.000439	0.00136	CcSEcCtD
Ticlopidine—Dermatitis—Captopril—systemic scleroderma	0.000439	0.00136	CcSEcCtD
Ticlopidine—Headache—Captopril—systemic scleroderma	0.000436	0.00135	CcSEcCtD
Ticlopidine—Dyspepsia—Lisinopril—systemic scleroderma	0.000434	0.00135	CcSEcCtD
Ticlopidine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000433	0.00134	CcSEcCtD
Ticlopidine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000432	0.00134	CcSEcCtD
Ticlopidine—Decreased appetite—Lisinopril—systemic scleroderma	0.000429	0.00133	CcSEcCtD
Ticlopidine—Eosinophilia—Methotrexate—systemic scleroderma	0.000426	0.00132	CcSEcCtD
Ticlopidine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000423	0.00131	CcSEcCtD
Ticlopidine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000423	0.00131	CcSEcCtD
Ticlopidine—Pain—Lisinopril—systemic scleroderma	0.000422	0.00131	CcSEcCtD
Ticlopidine—Diarrhoea—Azathioprine—systemic scleroderma	0.000416	0.00129	CcSEcCtD
Ticlopidine—Haemoglobin—Prednisone—systemic scleroderma	0.000415	0.00128	CcSEcCtD
Ticlopidine—Nausea—Captopril—systemic scleroderma	0.000414	0.00128	CcSEcCtD
Ticlopidine—Haemorrhage—Prednisone—systemic scleroderma	0.000412	0.00128	CcSEcCtD
Ticlopidine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000412	0.00128	CcSEcCtD
Ticlopidine—Asthenia—Leflunomide—systemic scleroderma	0.000412	0.00128	CcSEcCtD
Ticlopidine—Pancytopenia—Methotrexate—systemic scleroderma	0.000409	0.00127	CcSEcCtD
Ticlopidine—Pruritus—Leflunomide—systemic scleroderma	0.000406	0.00126	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000403	0.00125	CcSEcCtD
Ticlopidine—Dizziness—Azathioprine—systemic scleroderma	0.000402	0.00125	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000394	0.00122	CcSEcCtD
Ticlopidine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000393	0.00122	CcSEcCtD
Ticlopidine—Diarrhoea—Leflunomide—systemic scleroderma	0.000393	0.00122	CcSEcCtD
Ticlopidine—Urticaria—Lisinopril—systemic scleroderma	0.000392	0.00121	CcSEcCtD
Ticlopidine—Body temperature increased—Lisinopril—systemic scleroderma	0.00039	0.00121	CcSEcCtD
Ticlopidine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000388	0.0012	CcSEcCtD
Ticlopidine—Vomiting—Azathioprine—systemic scleroderma	0.000387	0.0012	CcSEcCtD
Ticlopidine—Rash—Azathioprine—systemic scleroderma	0.000383	0.00119	CcSEcCtD
Ticlopidine—Dermatitis—Azathioprine—systemic scleroderma	0.000383	0.00119	CcSEcCtD
Ticlopidine—Headache—Azathioprine—systemic scleroderma	0.000381	0.00118	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000381	0.00118	CcSEcCtD
Ticlopidine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000381	0.00118	CcSEcCtD
Ticlopidine—Dizziness—Leflunomide—systemic scleroderma	0.00038	0.00118	CcSEcCtD
Ticlopidine—Renal failure—Methotrexate—systemic scleroderma	0.000377	0.00117	CcSEcCtD
Ticlopidine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000376	0.00116	CcSEcCtD
Ticlopidine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000375	0.00116	CcSEcCtD
Ticlopidine—Pain—Mycophenolate mofetil—systemic scleroderma	0.00037	0.00115	CcSEcCtD
Ticlopidine—Haematuria—Methotrexate—systemic scleroderma	0.000366	0.00113	CcSEcCtD
Ticlopidine—Vomiting—Leflunomide—systemic scleroderma	0.000365	0.00113	CcSEcCtD
Ticlopidine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000364	0.00113	CcSEcCtD
Ticlopidine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000362	0.00112	CcSEcCtD
Ticlopidine—Epistaxis—Methotrexate—systemic scleroderma	0.000362	0.00112	CcSEcCtD
Ticlopidine—Rash—Leflunomide—systemic scleroderma	0.000362	0.00112	CcSEcCtD
Ticlopidine—Dermatitis—Leflunomide—systemic scleroderma	0.000362	0.00112	CcSEcCtD
Ticlopidine—Nausea—Azathioprine—systemic scleroderma	0.000361	0.00112	CcSEcCtD
Ticlopidine—Headache—Leflunomide—systemic scleroderma	0.00036	0.00111	CcSEcCtD
Ticlopidine—Asthenia—Lisinopril—systemic scleroderma	0.000354	0.0011	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000354	0.0011	CcSEcCtD
Ticlopidine—Pruritus—Lisinopril—systemic scleroderma	0.000349	0.00108	CcSEcCtD
Ticlopidine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000348	0.00108	CcSEcCtD
Ticlopidine—Haemoglobin—Methotrexate—systemic scleroderma	0.000346	0.00107	CcSEcCtD
Ticlopidine—Rash—Mycophenolic acid—systemic scleroderma	0.000345	0.00107	CcSEcCtD
Ticlopidine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000345	0.00107	CcSEcCtD
Ticlopidine—Haemorrhage—Methotrexate—systemic scleroderma	0.000345	0.00107	CcSEcCtD
Ticlopidine—Hepatitis—Methotrexate—systemic scleroderma	0.000345	0.00107	CcSEcCtD
Ticlopidine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000343	0.00106	CcSEcCtD
Ticlopidine—Headache—Mycophenolic acid—systemic scleroderma	0.000343	0.00106	CcSEcCtD
Ticlopidine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000342	0.00106	CcSEcCtD
Ticlopidine—Nausea—Leflunomide—systemic scleroderma	0.000341	0.00106	CcSEcCtD
Ticlopidine—Diarrhoea—Lisinopril—systemic scleroderma	0.000338	0.00105	CcSEcCtD
Ticlopidine—Angioedema—Prednisone—systemic scleroderma	0.000328	0.00102	CcSEcCtD
Ticlopidine—Dizziness—Lisinopril—systemic scleroderma	0.000326	0.00101	CcSEcCtD
Ticlopidine—Erythema multiforme—Methotrexate—systemic scleroderma	0.000326	0.00101	CcSEcCtD
Ticlopidine—Nausea—Mycophenolic acid—systemic scleroderma	0.000325	0.00101	CcSEcCtD
Ticlopidine—Tinnitus—Methotrexate—systemic scleroderma	0.000321	0.000996	CcSEcCtD
Ticlopidine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000319	0.000987	CcSEcCtD
Ticlopidine—Vomiting—Lisinopril—systemic scleroderma	0.000314	0.000972	CcSEcCtD
Ticlopidine—Rash—Lisinopril—systemic scleroderma	0.000311	0.000964	CcSEcCtD
Ticlopidine—Dermatitis—Lisinopril—systemic scleroderma	0.000311	0.000963	CcSEcCtD
Ticlopidine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00031	0.000961	CcSEcCtD
Ticlopidine—Headache—Lisinopril—systemic scleroderma	0.000309	0.000958	CcSEcCtD
Ticlopidine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000306	0.000948	CcSEcCtD
Ticlopidine—Arthralgia—Prednisone—systemic scleroderma	0.000306	0.000947	CcSEcCtD
Ticlopidine—Myalgia—Prednisone—systemic scleroderma	0.000306	0.000947	CcSEcCtD
Ticlopidine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000296	0.000917	CcSEcCtD
Ticlopidine—Nausea—Lisinopril—systemic scleroderma	0.000293	0.000908	CcSEcCtD
Ticlopidine—Anaphylactic shock—Prednisone—systemic scleroderma	0.000293	0.000908	CcSEcCtD
Ticlopidine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000286	0.000886	CcSEcCtD
Ticlopidine—Anorexia—Prednisone—systemic scleroderma	0.000279	0.000866	CcSEcCtD
Ticlopidine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000275	0.000852	CcSEcCtD
Ticlopidine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000273	0.000845	CcSEcCtD
Ticlopidine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000272	0.000844	CcSEcCtD
Ticlopidine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000271	0.000839	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000267	0.000827	CcSEcCtD
Ticlopidine—Dyspepsia—Prednisone—systemic scleroderma	0.000258	0.000799	CcSEcCtD
Ticlopidine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000257	0.000796	CcSEcCtD
Ticlopidine—Arthralgia—Methotrexate—systemic scleroderma	0.000255	0.000792	CcSEcCtD
Ticlopidine—Myalgia—Methotrexate—systemic scleroderma	0.000255	0.000792	CcSEcCtD
Ticlopidine—Decreased appetite—Prednisone—systemic scleroderma	0.000255	0.000789	CcSEcCtD
Ticlopidine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000245	0.000759	CcSEcCtD
Ticlopidine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.00024	0.000743	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00024	0.000743	CcSEcCtD
Ticlopidine—Anorexia—Methotrexate—systemic scleroderma	0.000233	0.000723	CcSEcCtD
Ticlopidine—Urticaria—Prednisone—systemic scleroderma	0.000233	0.000721	CcSEcCtD
Ticlopidine—Body temperature increased—Prednisone—systemic scleroderma	0.000232	0.000718	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000223	0.000691	CcSEcCtD
Ticlopidine—Hypersensitivity—Prednisone—systemic scleroderma	0.000216	0.000669	CcSEcCtD
Ticlopidine—Dyspepsia—Methotrexate—systemic scleroderma	0.000216	0.000668	CcSEcCtD
Ticlopidine—Decreased appetite—Methotrexate—systemic scleroderma	0.000213	0.00066	CcSEcCtD
Ticlopidine—Asthenia—Prednisone—systemic scleroderma	0.00021	0.000651	CcSEcCtD
Ticlopidine—Pain—Methotrexate—systemic scleroderma	0.000209	0.000649	CcSEcCtD
Ticlopidine—Pruritus—Prednisone—systemic scleroderma	0.000207	0.000642	CcSEcCtD
Ticlopidine—Diarrhoea—Prednisone—systemic scleroderma	0.000201	0.000621	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.0002	0.000621	CcSEcCtD
Ticlopidine—Urticaria—Methotrexate—systemic scleroderma	0.000195	0.000603	CcSEcCtD
Ticlopidine—Dizziness—Prednisone—systemic scleroderma	0.000194	0.0006	CcSEcCtD
Ticlopidine—Body temperature increased—Methotrexate—systemic scleroderma	0.000194	0.0006	CcSEcCtD
Ticlopidine—Vomiting—Prednisone—systemic scleroderma	0.000186	0.000577	CcSEcCtD
Ticlopidine—Rash—Prednisone—systemic scleroderma	0.000185	0.000573	CcSEcCtD
Ticlopidine—Dermatitis—Prednisone—systemic scleroderma	0.000185	0.000572	CcSEcCtD
Ticlopidine—Headache—Prednisone—systemic scleroderma	0.000184	0.000569	CcSEcCtD
Ticlopidine—Hypersensitivity—Methotrexate—systemic scleroderma	0.00018	0.000559	CcSEcCtD
Ticlopidine—Asthenia—Methotrexate—systemic scleroderma	0.000176	0.000544	CcSEcCtD
Ticlopidine—Nausea—Prednisone—systemic scleroderma	0.000174	0.000539	CcSEcCtD
Ticlopidine—Pruritus—Methotrexate—systemic scleroderma	0.000173	0.000537	CcSEcCtD
Ticlopidine—Diarrhoea—Methotrexate—systemic scleroderma	0.000168	0.000519	CcSEcCtD
Ticlopidine—Dizziness—Methotrexate—systemic scleroderma	0.000162	0.000502	CcSEcCtD
Ticlopidine—Vomiting—Methotrexate—systemic scleroderma	0.000156	0.000482	CcSEcCtD
Ticlopidine—Rash—Methotrexate—systemic scleroderma	0.000154	0.000478	CcSEcCtD
Ticlopidine—Dermatitis—Methotrexate—systemic scleroderma	0.000154	0.000478	CcSEcCtD
Ticlopidine—Headache—Methotrexate—systemic scleroderma	0.000153	0.000475	CcSEcCtD
Ticlopidine—Nausea—Methotrexate—systemic scleroderma	0.000145	0.000451	CcSEcCtD
